|Identification of maternal depression risk from natural language collected in a mobile health app.
Krishnamurti T, Allen K, Hayani L, Rodriguez S, Davis AL. Procedia Comput Sci. 2022;206:132-140.
Natural language from open-ended writing prompts in a prenatal care mobile health app and self-reported daily mood, were entered by patients using the tool. Open-ended text within a 30-day and 60-day timeframe of completing an EPDS was found to be moderately predictive of moderate to severe depression risk (AUROC=0.66 and 0.67, for each respective timeframe). When combined with average daily reported mood, open-ended text showed good predictive power (AUROC=0.87).
A pilot randomized controlled trial of a lay telephone coaching and web-based intervention for postpartum depression and anxiety: The MPOWER study.
Schwartz H, McCusker J, Da Costa D, Singh S, Baskaran S, Belzile E, Van Roost K.
Internet Interv. 2022 Dec 23;31:100597.
The estimates of the effect of the intervention on mental health outcomes at 6-months were imprecise but point estimates and confidence intervals were consistent with a moderate beneficial effect of the intervention on both symptoms of depression and anxiety (fully adjusted effects sizes: 0.51 (95 % CI: [-0.14, 1.17]) and 0.56 (95 % CI: [-0.09, 1.22]), respectively).
Relationship between antenatal sleep quality and depression in perinatal women: A comprehensive meta-analysis of observational studies.
Fu T, Wang C, Yan J, Zeng Q, Ma C. J Affect Disord. 2023 Feb 3;327:38-45.
In this meta-analysis, women who experienced poor sleep quality during pregnancy were at a significantly higher risk of developing antenatal depression (3.72 times higher) and postpartum depression (2.71 times higher).
Association between sleep disorders during pregnancy and risk of postpartum depression: a systematic review and meta-analysis.
Li H, Li H, Zhong J, Wu Q, Shen L, Tao Z, Zhang H, Song S. Arch Womens Ment Health. 2023 Feb 4.
Meta-analysis indicated that sleep disorders during pregnancy resulted in a statistically significant increased risk of PPD (OR: 2.36 95% CI: 1.72, 2.32).
Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression.
Deligiannidis KM, Citrome L, Huang MY, Acaster S, Fridman M, Bonthapally V, Lasser R, Kanes SJ. J Clin Psychiatry. 2023 Jan 30;84(1):22m14475.
Zuranolone was associated with concurrent improvements in depressive and anxiety symptoms, with beneficial effects on insomnia symptoms and patient-perceived functional health in adults with PPD.